Roth/MKM Downgrades Avidity Biosciences (RNA) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY

6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Price: $14.82 -4.2%

Rating Summary:
11 Buy, 12 Hold, 0 Sell

Rating Trend: Down

Down

Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0

Roth/MKM analyst Boobalan Pachaiyappan downgraded Avidity Biosciences (NASDAQ: RNA) from Buy to Neutral.

For an analyst ratings summary and ratings history on Avidity Biosciences click here. For more ratings news on Avidity Biosciences click here.

Shares of Avidity Biosciences closed at $49.15 yesterday.

Downgrades

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!